Table 3. Linear regression analysis identifying predictors of cutaneous psoriasis severity.
| Variables | Univariable analysis | Multivariable analysis | |||
|---|---|---|---|---|---|
| β | p | Adjusted β | p | ||
| Disease duration | 0.04 | 0.364 | |||
| Family history | −1.38 | 0.225 | |||
| Clinical characteristics | |||||
| Scalp involvement | 2.19 | 0.012 | 1.55 | 0.067 | |
| Nail change | 3.35 | <0.001 | 2.92 | <0.001 | |
| Peripheral arthritis | 0.31 | 0.777 | |||
| Axial arthritis | 0.67 | 0.551 | |||
| Enthesopathy | 3.07 | 0.081 | |||
| Psoriatic arthritis | 2.89 | 0.011 | 1.89 | 0.089 | |
| Laboratory parameters | |||||
| ESR | 0.01 | 0.680 | |||
| RDW | −0.08 | 0.848 | |||
| CRP | 0.03 | 0.728 | |||
| Negative RF* | 2.52 | 0.193 | |||
| HLA-B27 positivity | −0.94 | 0.504 | −1.18 | 0.384 | |
ESR: erythrocyte sedimentation rate, RDW: red cell distribution width, CRP: C-reactive protein, RF: rheumatoid factor.
*Negative RF was defined as <15 IU/ml.